Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report

Bibliographic Details
Main Authors:	Angela L. Liang, Payam Katebi Kashi, Mark Hopkins, Anna Beavis, Stephanie Gaillard, Ie-Ming Shih, Amanda N. Fader
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	Gynecologic Oncology Reports
Subjects:	Uterine carcinosarcoma Hormone receptors Aromatase inhibitors Progestin therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578921001818

Similar Items

Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report
by: P. Martin-Romano, et al.
Published: (2017-04-01)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021-08-01)

Hormonal therapy in uterine sarcomas
by: Yuqin Zang, et al.
Published: (2019-04-01)

Involvement of Membrane Progestin Receptor Beta (mPRβ/Paqr8) in Sex Pheromone Progestin-Induced Expression of Luteinizing Hormone in the Pituitary of Male Chinese Black Sleeper (Bostrychus Sinensis)
by: Yu Ting Zhang, et al.
Published: (2018-07-01)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
by: Myriam Gracia, et al.
Published: (2023-02-01)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
by: Dong Teng Liu, et al.
Published: (2018-09-01)

Understanding Progestins: From Basics to Clinical Applicability
by: Manuel García-Sáenz, et al.
Published: (2023-05-01)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
by: Mu Lv, et al.
Published: (2022-12-01)

Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
by: Ashley V. Ward, et al.
Published: (2022-03-01)

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
by: İrfan Cicin, et al.
Published: (2016-10-01)

Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma
by: Rasiah Bharathan, et al.
Published: (2024-01-01)

Estro-Progestins and Pain Relief in Endometriosis
by: Libera Troìa, et al.
Published: (2022-06-01)

Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
by: T Ashrafganjoei, et al.
Published: (2015-12-01)

Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease
by: Monica Dandapani, et al.
Published: (2015-11-01)

Uterine cervical carcinosarcoma; very rare and aggressive behavior; literature review
by: Özer Birge, et al.
Published: (2021-04-01)

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
by: Tahireh Markert, et al.
Published: (2022-04-01)

Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
by: Daniela Roxana Matasariu, et al.
Published: (2023-07-01)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
by: Meghan S. Perkins, et al.
Published: (2022-09-01)

Clinically aggressive “low-grade” uterine carcinosarcoma: A case report
by: Theresa Clearman, et al.
Published: (2015-11-01)

Emergency contraception using progestin drugs in domestic cats
by: A. Vasetska
Published: (2020-05-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report
by: A. ElNaggar, et al.
Published: (2022-02-01)

Outcome and predictive factors in uterine carcinosarcoma using postoperative radiotherapy: a Rare Cancer Network study
by: Daniel R. Zwahlen, et al.
Published: (2016-06-01)

A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand
by: Kulisara Nanthamongkolkul, et al.
Published: (2023-05-01)

Anticonceptivos orales de sólo progestina Progestin only-oral contraceptives
by: Alvaro Monterrosa
Published: (2006-03-01)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
by: Huseyin Salih SEMIZ, et al.
Published: (2023-01-01)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
by: Fengping Shao, et al.
Published: (2023-06-01)

Carcinosarcoma of the Uterine Corpus with Alpha-Fetoprotein-Producing Hepatoid Adenocarcinoma: A Report of Two Cases
by: Ryuji Kawaguchi, et al.
Published: (2011-07-01)

Perbandingan Kepadatan Mineral Tulang Antar Pemakai Kontrasepsi Hormonal Progestin dan Kontrasepsi Non Hormonal pada Wanita Usia Subur
by: Aprilina Aprilina, et al.
Published: (2020-05-01)

Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
by: Korhan Kahraman, et al.
Published: (2012-03-01)

Hypoluteoidism in a dog associated with recurrent mammary fibroadenoma stimulated by progestin therapy
by: Maria Teresa Zedda, et al.
Published: (2017-09-01)

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study
by: Günsu Kimyon Cömert, et al.
Published: (2019-07-01)

Differences In Fasting Blood Glucose Levels In Acceptors Progestin Injections And Combination Injections
by: Siti Cholifah, et al.
Published: (2020-11-01)

A rodent model of human dose-equivalent progestin-only implantable contraception
by: Heather C. M. Allaway, et al.
Published: (2021-03-01)

Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety
by: Jon-Benay Mitchell, et al.
Published: (2022-12-01)

Non-islet cell tumor hypoglycemia in a patient with uterine carcinosarcoma
by: Miller P. Singleton, et al.
Published: (2022-02-01)

High levels of progesterone receptor B in MCF-7 cells enable radical anti-tumoral and anti-estrogenic effect of progestin
by: Bajalovic, Natasa, et al.
Published: (2023)

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study
by: Yuan Li, et al.
Published: (2019-07-01)

Survival analysis of patients with rare tumors of the uterine corpus – carcinosarcoma
by: Stevanović Nemanja, et al.
Published: (2024-01-01)